Jeffrey L. Dage, Ph.D. is a Senior Research Professor of Neurology at Indiana University School of Medicine. He holds a secondary appointment in the Department of Medical and Molecular Genetics. He is the co-leader of the genetics biomarker and biosample core of the Indiana Alzheimer’s Research Center and of the Longitudinal Early Onset Alzheimer’s Disease Study. Dr. Dage is also affiliated with Stark Neurosciences Research Institute at Indiana University School of Medicine. Prior to joining IUSM, Dr. Dage worked for Eli Lilly and Company for over 20 years where he pioneered the development of assays for measuring phosphorylated tau in blood.
A new digital experience is coming Fall 2025. ALZpath is evolving — and so is our website.